NanoInk Management Team

James M. Hussey
Chief Executive Officer, member of the Board of Directors

James M. Hussey joined NanoInk, as Chief Executive Officer and member of the Board of Directors, in January 2008. Mr. Hussey brings 25 years of experience in the pharmaceutical and biotechnology industry as executive, founder, investor and consultant to senior management and boards of directors. Prior to joining NanoInk, Mr. Hussey was with Ovation Pharmaceuticals, where he was a member of the senior operating committee, serving as Head of Alliances and Vice President of Corporate Development. He was President and CEO of NeoPharm, Inc., as well as a member of the Board of Directors and an investor/shareholder. In 1994, he founded Physicians Quality Care, a health care services IPA Management Company, which was sold to a public company in 1998. Prior to founding Physicians Quality Care, he was with Bristol Myers Squibb in Princeton, New Jersey, serving as General Manager as well as other positions in marketing, new business development and sales. Mr. Hussey holds a B.S. in Pharmacy from Butler University, Indianapolis, Indiana, and an M.B.A. from University of Illinois at Chicago.

Robert J. Janosky
President and Chief Operating Officer

Robert J. Janosky joined NanoInk in July 2006 as President and Chief Operating Officer where he is responsible for guiding NanoInk's operations. Mr. Janosky brings over 35 years of operational experience and significant pharmaceutical manufacturing expertise to NanoInk. Most recently, he served as vice president of manufacturing at Cubist Pharmaceuticals, a publicly traded biopharmaceutical company focused on developing and commercializing anti-infective therapies for the acute care environment. Mr. Janosky also served as vice president of manufacturing at Warner Lambert and as the president and general manager of the company's Puerto Rico office. He has also held other senior management positions with Cardinal Health, Rhône Poulenc-Rorer and Bristol Myers. He received his B.S. in Science and Chemistry from Gannon University.

Ben Pothast
Chief Financial Officer

Ben Pothast joined NanoInk in February 2008 as Chief Financial Officer. Mr. Pothast brings over 20 years of diverse financial experience to NanoInk. Most recently, he served as Chief Financial Officer at Cambridge Major Laboratories, Inc., a privately held service-based chemistry outsourcing partner to the world's leading pharmaceutical and biotechnology companies. Mr. Pothast also served as Vice President of Planning and Analysis at Ovation Pharmaceuticals where he was responsible for all treasury and portfolio management functions. Prior to joining Ovation, Mr. Pothast was Chief Financial Officer at Akorn, Inc., a specialty pharmaceutical company that develops, manufactures and markets ophthalmic and injectable products. Mr. Pothast began his career at Ernst & Young and is a Certified Public Accountant. He holds a B.A. degree in Accounting and Business Administration from Augustana College and a Masters of Management degree from the Kellogg Graduate School of Management at Northwestern University.

Dean Hart
Chief Commercial Officer

Dean Hart joined NanoInk in February 2008 and brings over 25 years of sales and marketing experience to NanoInk. Most recently, he served as Vice President of Sales and Marketing at Vision Point of Sale, Inc., a leading point of sale equipment and services company. Mr. Hart also served as Senior Vice President of Sales at Takeda Pharmaceuticals North America where he led a sales force numbering in excess of 2,500 in successfully meeting sales and profit goals. Prior to joining Takeda, he served as president of Sequest Technologies, a healthcare software company, and as national sales director for Eisai, Inc., where he built the sales organization and successfully launched Eisai's first product in the U.S. pharmaceutical marketplace. He began his career at Bristol-Myers Squibb. Mr. Hart received a B.S. degree in Business Management from Indiana University and a Masters of Business Administration degree from the Kellogg School of Management at Northwestern University.

Michael Nelson
Chief Technology Officer

Michael Nelson joined NanoInk in March 2002. Mr. Nelson has over 25 years experience directing project teams and departments through all phases of new product development in companies ranging from small start-ups through Fortune 500 corporations.  He has a highly successful record integrating technology and operations to transform innovative concepts into commercially successful products. Prior to joining NanoInk, Mr. Nelson served as the Senior Vice President of Engineering at Molecular Diagnostics, Inc., where he directed the design and development of innovative screening systems to assist in the early detection of cancer. As the Vice President of Systems Development, for AccuMed International, Inc., he managed contract research and development for a number of healthcare industry clients. He earned his master's degree in computer science and M.B.A. degree from DePaul University in Chicago.

Joe Fragala
Vice President of Microfabrication

Joe Fragala joined NanoInk as Vice President of Microfabrication in 2002. Mr. Fragala brings over 20 years of semiconductor and MEMS experience. Prior to joining NanoInk, he served as a manager of the silicon production plant at Endevco where he led development of new products and production of over 60 different MEMS sensors-including variable capacitive and piezoresistive devices. Previously, Mr. Fragala worked at NASA JPL as a member of the Technical Staff designing and fabricating a high-resolution tunneling accelerometer. He also worked at Kavlico Corporation (a Solectron Company) as program manager, Viggo-Spectramed as an R&D engineer, and ITT Semiconductor as a process engineer. Mr. Fragala earned his bachelor's degree in chemistry in 1982 from the College of the Holy Cross in Massachusetts.

Bruce Dudzik
Vice President of Nano BioDiscovery Division

Bruce Dudzik is the Vice President of the Nano BioDiscovery Division, focusing on partnerships exploiting NanoInk's DPN applications in the life science field. Mr. Dudzik joined NanoInk from Affymetrix in 2006, and brings over 25 years of experience in research, marketing, and business development in the microarray and bioscience industry. He has served at senior levels of business development at Affymetrix, a market leader in the gene chip microarray segment, and senior level business development and marketing positions at Amersham, Vysis, and Amoco Biotechnology Division. At both Affymetrix and Amersham, Mr. Dudzik was successful in closing many licensing agreements, technology acquisitions and strategic partnerships. He has been involved in developing new businesses and markets in the genomics and biotech space in many of his previous roles. Mr. Dudzik received a B.S. in biology from the University of Illinois and an M.B.A. from DePaul University.

Haris Jamil, Ph.D.
Vice President of NanoStem Cell Division

Haris Jamil, Ph.D. joined NanoInk in July 2008 as Vice President of the NanoStem Cell Division. Dr. Jamil brings 25 years of research experience, including 17 years of drug discovery and drug development experience. He previously held key positions at Bristol-Myers Squibb, NeoPharm and Ovation Pharmaceutical Companies. At Ovation and NeoPharm, he managed multiple pre-clinical and clinical stage drug development projects and advanced 11 drug candidates at various stages of clinical trials. At NeoPharm he was VP of R&D and led business development and licensing activities to enable the development and commercialization of pipeline products. He also served on the sales and marketing team for siRNA delivery reagent for drug discovery and therapeutic applications. Dr. Jamil has published 35 full length papers and 3 review articles in high profile journals and submitted 10 patent applications. He has served on the Editorial Board of Analytical Biochemistry for more than 10 years. He earned his Ph.D. in Biochemistry at the University of London.

Tom Warwick
General Manager of NanoFabrication Systems Division

Tom Warwick joined NanoInk in April 2009 as General Manager of the NanoFabrication Systems Division. Mr. Warwick brings over 20 years international sales marketing and product management experience to NanoInk. For the previous eleven years Mr. Warwick held a variety of positions at Veeco Instruments, a leading provider of metrology and deposition equipment. Upon leaving he held both a VP Global Sales and GM European Operations role with P&L responsibility. The bulk of his market experience is in selling instrumentation to academics and to R&D departments in industry. He has also sold metrology and deposition equipment to the semiconductor, High Brightness LED and solar markets. Tom's first position in nanotechnology was in the early nineties where he was the first commercial person at a Cambridge UK based manufacturer of Ultra High Vacuum Scanning Tunneling Microscopy, having doubled the sales turnover twice. The business was sold to Oxford Instruments, where Mr. Warwick stayed on for a further two years. Mr. Warwick received a BSc degree in Cell and Molecular Biology from the University of Essex and has studied a finance module at The London Business School.